The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The anti-tumor effect of Fecalibaculum has been discovered38,39.”
From Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy (2023) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Near-optimal probabilistic RNA-seq quantification
Bray, N. L., Pimentel, H., Melsted, P., & Pachter, L. (2016) · Nature Biotechnology · doi:10.1038/nbt.3519 · Cited by 9,723
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812 · cited 1×
“Other groups have made progress in understanding how antibiotics affect immunogenic cancers (Gopalakrishnan et al., 2018; Matson et al., 2018; Routy et al., 2018; Vetizou et al., 2015); however, to date, only a small number of studies have looked at their effects on BrCa (Buchta Rosean et al.,…”
BackgroundCommensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., Luke, J. J., & Gajewski, T. F. (2018) · Science · doi:10.1126/science.aao3290 · Cited by 3,107 · cited 1×
“Other groups have made progress in understanding how antibiotics affect immunogenic cancers (Gopalakrishnan et al., 2018; Matson et al., 2018; Routy et al., 2018; Vetizou et al., 2015); however, to date, only a small number of studies have looked at their effects on BrCa (Buchta Rosean et al.,…”
BackgroundSingle-cell transcriptomics of 20 mouse organs creates a Tabula Muris
The Tabula Muris Consortium, coordination, O., coordination, L., processing, O. C. A., sequencing, L. P. A., analysis, C. D., annotation, C. T., Writing group, Supplemental text writing group, & Principal investigators (2018) · Nature · doi:10.1038/s41586-018-0590-4 · Cited by 2,842
Beghini, F., McIver, L. J., Blanco-Míguez, A., Dubois, L., Asnicar, F., Maharjan, S., Mailyan, A., Manghi, P., Scholz, M., Thomas, A. M., et al. (2021) · eLife · doi:10.7554/elife.65088 · Cited by 2,303
Metagenomic microbial community profiling using unique clade-specific marker genes
Segata, N., Waldron, L., Ballarini, A., Narasimhan, V., Jousson, O., & Huttenhower, C. (2012) · Nature Methods · doi:10.1038/nmeth.2066 · Cited by 1,776 · cited 1×
“0 (Segata et al., 2012) R package ggplot2 Wickham, 2016 R package FastQC (Andrews, 2010) 0.11.3 FASTX-Toolkit (Hannon, 2010) 0.1.5 Tophat (Kim et al., 2013) 2.1.1 Cufflinks (Trapnell et al., 2013) 2.1.0 Kallisto (Bray et al., 2016) R package DeSeq2 (Love et al., 2014) R Package Cell ranger v2.”
InfluentialA defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Tanoue, T., Morita, S., Plichta, D. R., Skelly, A. N., Suda, W., Sugiura, Y., Narushima, S., Vlamakis, H., Motoo, I., Sugita, K., et al. (2019) · Nature · doi:10.1038/s41586-019-0878-z · Cited by 1,145
Flagged first, then by citations
Research works printed but not linked: 79
- Allegrezza, 2016, Trametinib drives T-cell-dependent control of KRAS-mutated tumors by inhibiting pathological myelopoiesis, Cancer Res., 76, 6253, 10.1158/0008-5472.CAN-16-1308 · DOI
- Aminov, 2010, A brief history of the antibiotic era: lessons learned and challenges for the future, Front Microbiol., 1, 134, 10.3389/fmicb.2010.00134 · DOI · Paper page
- Aponte-Lopez, 2018, Mast cell, the neglected member of the tumor microenvironment: role in breast cancer, J. Immunol. Res., 2018, 2584243
- Appleyard, 2011, Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer, Am. J. Physiol. Gastrointest. Liver Physiol., 301, G1004, 10.1152/ajpgi.00167.2011 · DOI
- Becattini, 2016, Antibiotic-induced changes in the intestinal microbiota and disease, Trends Mol. Med., 22, 458, 10.1016/j.molmed.2016.04.003 · DOI · Paper page
- Becht, 2018, Dimensionality reduction for visualizing single-cell data using UMAP, Nat. Biotechnol., 37, 38, 10.1038/nbt.4314 · DOI · Paper page
- Benito, 2017, Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell metabolic reprogramming and correlate with poor patient outcome, Oncotarget, 8, 106693, 10.18632/oncotarget.21601 · DOI
- Boyd, 2007, Mammographic density and the risk and detection of breast cancer, N. Engl. J. Med., 356, 227, 10.1056/NEJMoa062790 · DOI
- Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 68, 394
- Buchfink, 2015, Fast and sensitive protein alignment using DIAMOND, Nat. Methods, 12, 59, 10.1038/nmeth.3176 · DOI · Paper page
- Buchta Rosean, 2019, Preexisting commensal dysbiosis is a host-intrinsic regulator of tissue inflammation and tumor cell dissemination in hormone receptor-positive breast cancer, Cancer Res., 79, 3662, 10.1158/0008-5472.CAN-18-3464 · DOI
- Bush, 2016, β-Lactams and β-lactamase inhibitors: an overview, Cold Spring Harb. Perspect. Med., 6, a025247, 10.1101/cshperspect.a025247 · DOI · Paper page
- Carmi, 2015, Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity, Nature, 521, 99, 10.1038/nature14424 · DOI
- Castagnoli, 2014, Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab, Cancer Res., 74, 6248, 10.1158/0008-5472.CAN-14-0983 · DOI
- Chen, 2018, fastp: an ultra-fast all-in-one FASTQ preprocessor, Bioinformatics, 34, i884, 10.1093/bioinformatics/bty560 · DOI · Paper page
- Correa-Oliveira, 2016, Regulation of immune cell function by short-chain fatty acids, Clin. Transl Immunol., 5, e73, 10.1038/cti.2016.17 · DOI · Paper page
- Croswell, 2009, Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection, Infect. Immun., 77, 2741, 10.1128/IAI.00006-09 · DOI
- De Zuani, 2018, Mast cells at the crossroads of microbiota and IBD, Eur. J. Immunol., 48, 1929, 10.1002/eji.201847504 · DOI
- DeNardo, 2009, CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages, Cancer Cell, 16, 91, 10.1016/j.ccr.2009.06.018 · DOI
- DiLillo, 2010, B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice, J. Immunol., 184, 4006, 10.4049/jimmunol.0903009 · DOI
- Dudeck, 2011, Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens, Immunity, 34, 973, 10.1016/j.immuni.2011.03.028 · DOI
- Edwards, 2014, Use of prophylactic postoperative antibiotics during surgical drain presence following mastectomy, Ann. Surg. Oncol., 21, 3249, 10.1245/s10434-014-3960-7 · DOI
- Ewens, 2005, Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma, Anticancer Res., 25, 3905
- Feyerabend, 2011, Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity, Immunity, 35, 832, 10.1016/j.immuni.2011.09.015 · DOI
- Franzosa, 2018, Species-level functional profiling of metagenomes and metatranscriptomes, Nat. Methods, 15, 962, 10.1038/s41592-018-0176-y · DOI · Paper page
- Grimbaldeston, 2005, Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo, Am. J. Pathol., 167, 835, 10.1016/S0002-9440(10)62055-X · DOI
- Guan, 2020, Gut microbiota profiling in patients with HER2-negative metastatic breast cancer receiving metronomic chemotherapy of capecitabine compared to those under conventional dosage, Front. Oncol., 10, 902, 10.3389/fonc.2020.00902 · DOI
- Han, 2018, Mapping the mouse cell atlas by microwell-seq, Cell, 172, 1091, 10.1016/j.cell.2018.02.001 · DOI · Paper page
- He, 2021, Changes of intestinal microflora of breast cancer in premenopausal women, Eur. J. Clin. Microbiol. Infect. Dis., 40, 503, 10.1007/s10096-020-04036-x · DOI
- He, 2016, Mammary tumor growth and metastasis are reduced in c-Kit mutant Sash mice, Cancer Med., 5, 1292, 10.1002/cam4.696 · DOI
- Hothorn, 2008, Implementing a class of permutation tests: the coin package, J. Stat. Softw., 28, 1
- Huo, 2018, High mammographic density in women is associated with protumor inflammation, Breast Cancer Res., 20, 92, 10.1186/s13058-018-1010-2 · DOI
- Jones, 2014, Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery, Cochrane Database Syst. Rev., 9, CD005360
- Kelly, 2012, Microbiome and immunological interactions, Nutr. Rev., 70, S18, 10.1111/j.1753-4887.2012.00498.x · DOI
- Kim, 2013, TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions, Genome Biol., 14, R36, 10.1186/gb-2013-14-4-r36 · DOI · Paper page
- Lakritz, 2014, Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice, Int. J. Cancer, 135, 529, 10.1002/ijc.28702 · DOI
- Lechowski, 2013, Combined arginine and glutamine decrease release of de novo synthesized leukotrienes and expression of proinflammatory cytokines in activated human intestinal mast cells, Eur. J. Nutr., 52, 505, 10.1007/s00394-012-0353-1 · DOI
- Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol., 15, 550, 10.1186/s13059-014-0550-8 · DOI · Paper page
- Marchini, 2011, The human splice variant Delta16HER2 induces rapid tumor onset in a reporter transgenic mouse, PLoS One, 6, e18727, 10.1371/journal.pone.0018727 · DOI
- Mazurek, 1980, A binding site on mast cells and basophils for the anti-allergic drug cromolyn, Nature, 286, 722, 10.1038/286722a0 · DOI
- McCafferty, 2013, Stochastic changes over time and not founder effects drive cage effects in microbial community assembly in a mouse model, ISME J., 7, 2116, 10.1038/ismej.2013.106 · DOI · Paper page
- McCoy, 2017, Efficient genome-wide association in biobanks using topic modeling identifies multiple novel disease loci, Mol. Med., 23, 285, 10.2119/molmed.2017.00100 · DOI
- Metzger-Filho, 2013, Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX, J. Clin. Oncol., 31, 3083, 10.1200/JCO.2012.46.1574 · DOI
- Mullard, 2016, Tackling antimicrobial drug resistance, Nat. Rev. Drug Discov., 15, 375
- Naeini, 2019, Antitumor effects of curcumin: a lipid perspective, J. Cell Physiol, 234, 14743, 10.1002/jcp.28262 · DOI
- Oka, 2012, Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice, Lab. Invest., 92, 1472, 10.1038/labinvest.2012.116 · DOI
- Parhi, 2020, Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression, Nat. Commun., 11, 3259, 10.1038/s41467-020-16967-2 · DOI · Paper page
- Perez-Solis, 2016, Effects of the lifestyle habits in breast cancer transcriptional regulation, Cancer Cell Int, 16, 7, 10.1186/s12935-016-0284-7 · DOI
- Qian, 2010, Macrophage diversity enhances tumor progression and metastasis, Cell, 141, 39, 10.1016/j.cell.2010.03.014 · DOI
- Ranganathan, 2018, Antibiotic prophylaxis after immediate breast reconstruction: the reality of its efficacy, Plast. Reconstr. Surg., 141, 865, 10.1097/PRS.0000000000004204 · DOI
- Rao, 2006, Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice, Cancer Res., 66, 7395, 10.1158/0008-5472.CAN-06-0558 · DOI
- Rasouli, 2017, In vitro activity of probiotic Lactobacillus reuteri against gastric cancer progression by downregulation of urokinase plasminogen activator/urokinase plasminogen activator receptor gene expression, J. Cancer Res. Ther., 13, 246, 10.4103/0973-1482.204897 · DOI
- Reikvam, 2011, Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression, PLoS One, 6, e17996, 10.1371/journal.pone.0017996 · DOI
- Rooks, 2016, Gut microbiota, metabolites and host immunity, Nat. Rev. Immunol., 16, 341, 10.1038/nri.2016.42 · DOI · Paper page
- Rossini, 2006, Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice, Cancer Res., 66, 6219, 10.1158/0008-5472.CAN-05-4592 · DOI
- Schwarzer, 2019, Germ-free mice exhibit mast cells with impaired functionality and gut homing and do not develop food allergy, Front. Immunol., 10, 205, 10.3389/fimmu.2019.00205 · DOI
- Stuart, 2019, Comprehensive integration of single-cell data, Cell, 177, 1888, 10.1016/j.cell.2019.05.031 · DOI · Paper page
- Su, 2016, Antagonizing integrin beta3 increases immunosuppression in cancer, Cancer Res., 76, 3484, 10.1158/0008-5472.CAN-15-2663 · DOI
- Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 71, 209
- Tao, 2015, Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10, Eur. J. Immunol., 45, 999, 10.1002/eji.201444625 · DOI
- Teng, 2021, Exploring the impact of gut microbiota and diet on breast cancer risk and progression, Int. J. Cancer, 149, 494, 10.1002/ijc.33496 · DOI
- Tomayko, 1989, Determination of subcutaneous tumor size in athymic (nude) mice, Cancer Chemother. Pharmacol., 24, 148, 10.1007/BF00300234 · DOI · Paper page
- Trapnell, 2013, Differential analysis of gene regulation at transcript resolution with RNA-seq, Nat. Biotechnol., 31, 46, 10.1038/nbt.2450 · DOI · Paper page
- Tremaroli, 2012, Functional interactions between the gut microbiota and host metabolism, Nature, 489, 242, 10.1038/nature11552 · DOI · Paper page
- University of California Los Angeles. Department of Statistics., and Foundation for Open Access Statistics. Journal of statistical software. Foundation for Open Access Statistics. UCLA Statistics
- Varricchi, 2017, Are mast cells MASTers in cancer?, Front Immunol., 8, 424, 10.3389/fimmu.2017.00424 · DOI
- Velicer, 2004, Antibiotic use in relation to the risk of breast cancer, JAMA, 291, 827, 10.1001/jama.291.7.827 · DOI
- Velicer, 2006, Association between antibiotic use prior to breast cancer diagnosis and breast tumour characteristics (United States), Cancer Causes Control, 17, 307
- Viaud, 2013, The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide, Science, 342, 971, 10.1126/science.1240537 · DOI · Paper page
- Wagner, 2019, A single-cell atlas of the tumor and immune ecosystem of human breast cancer, Cell, 177, 1330, 10.1016/j.cell.2019.03.005 · DOI
- Wang, 2018, Sodium butyrate enhances intestinal integrity, inhibits mast cell activation, inflammatory mediator production and JNK signaling pathway in weaned pigs, Innate Immun., 24, 40, 10.1177/1753425917741970 · DOI
- Wood, 2019, Improved metagenomic analysis with Kraken 2, Genome Biol., 20, 257, 10.1186/s13059-019-1891-0 · DOI
- Wu, 2020, Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study, Breast Cancer Res. Treat, 182, 451, 10.1007/s10549-020-05702-6 · DOI
- Wu, 2013, Dysbiosis signature of fecal microbiota in colorectal cancer patients, Microb. Ecol., 66, 462, 10.1007/s00248-013-0245-9 · DOI · Paper page
- Yuen, 2016, B lymphocytes and cancer: a love-hate relationship, Trends Cancer, 2, 747, 10.1016/j.trecan.2016.10.010 · DOI · Paper page
- Zagato, 2020, Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth, Nat. Microbiol., 5, 511, 10.1038/s41564-019-0649-5 · DOI · Paper page
- Zhang, 2016, Mast cell stabilisers, Eur. J. Pharmacol., 778, 158, 10.1016/j.ejphar.2015.05.071 · DOI
- Zhang, 2019, KDM5B promotes breast cancer cell proliferation and migration via AMPK-mediated lipid metabolism reprogramming, Exp. Cell Res, 379, 182, 10.1016/j.yexcr.2019.04.006 · DOI
- Zitvogel, 2017, Nutrition, inflammation and cancer, Nat. Immunol., 18, 843, 10.1038/ni.3754 · DOI · Paper page
Cited by
Sorted by citations
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Thomas, A. M., Fidelle, M., Routy, B., Kroemer, G., Wargo, J. A., Segata, N., & Zitvogel, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00785-8 · Cited by 141
Lang, T., Zhu, R., Zhu, X., Yan, W., Li, Y., Zhai, Y., Wu, T., Huang, X., Yin, Q., & Li, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-40439-y · Cited by 133
Metadata
- Authors
- McKee, A. M., Kirkup, B. M., Madgwick, M., Fowler, W. J., Price, C. A., Dreger, S. A., Ansorge, R., Makin, K. A., Caim, S., Le Gall, G., Paveley, J., Leclaire, C., Dalby, M., Alcon-Giner, C., Andrusaite, A., Feng, T.-Y., Di Modica, M., Triulzi, T., Tagliabue, E., Milling, S. W. F., Weilbaecher, K. N., Rutkowski, M. R., Korcsmáros, T., Hall, L. J., & Robinson, S. D.
- Venue
- iScience
- Publisher
- Elsevier BV
- Published
- 2021-09
- Volume
- 24
- Issue
- 9
- Pages
- 103012
- ISSN
- 2589-0042
- PMC
- PMC8426205
- Cited by
- 81
- References
- 14
- Language
- en
- Licence
- Funders
- Breast Cancer Now (2017NovPhD973)
- Wellcome Trust (100974/C/13/Z)
- Susan G Komen Breast Cancer Foundation
- Biotechnology and Biological Sciences Research Council (BB/S50743X/1, BB/M011216/1, 20264, BBS/E/F/000PR10353, BBS/E/F/000PR10355, BB/R012490/1, BB/J014524/1, BB/J004529/1, BB/P016774/1)
- UVA Cancer Center
- Quadram Institute Bioscience
- UK Research and Innovation
- Cancer Research UK (C18281/A29019)
- National Cancer Institute (P30CA44570, P30 CA44579)
- Associazione Italiana per la Ricerca sul Cancro
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review